The novel atypical retinoid ST5589 down-regulates Aurora Kinase A and has anti-tumour activity in lymphoma pre-clinical models.

about

The synthetic retinoid ST1926 as a novel therapeutic agent in rhabdomyosarcoma.Accelerated inflammation and oxidative stress induced by LPS in acute lung injury: Ιnhibition by ST1926.

P2860

Q38829089-CC57FFD8-85E9-4054-A490-BC28996870BA Q52641349-E75F5147-6C06-44E7-8375-B71189CA2E69

P2860

The novel atypical retinoid ST5589 down-regulates Aurora Kinase A and has anti-tumour activity in lymphoma pre-clinical models.

Item

http://www.wikidata.org/entity/Q38847105

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The novel atypical retinoid ST ...... lymphoma pre-clinical models.

@en

type

Item

label

The novel atypical retinoid ST ...... lymphoma pre-clinical models.

@en

prefLabel

The novel atypical retinoid ST ...... lymphoma pre-clinical models.

@en

P1476

The novel atypical retinoid ST ...... n lymphoma pre-clinical models

@en

P2093

Afua Adjeiwaa Mensah

http://www.w3.org/2001/XMLSchema#string

Anastasios Stathis

http://www.w3.org/2001/XMLSchema#string

Andrea Rinaldi

http://www.w3.org/2001/XMLSchema#string

Chiara Tarantelli

http://www.w3.org/2001/XMLSchema#string

Elena Bernasconi

http://www.w3.org/2001/XMLSchema#string

Eugenio Gaudio

http://www.w3.org/2001/XMLSchema#string

Giuseppe Giannini

http://www.w3.org/2001/XMLSchema#string

Ivo Kwee

http://www.w3.org/2001/XMLSchema#string

Loredana Vesci

http://www.w3.org/2001/XMLSchema#string

P2860

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Tcl1 interacts with Atm and enhances NF-κB activation in hematologic malignancies.

ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis.

Atypical retinoids: an expanding series of anti-leukemia and anti-cancer agents endowed with selective apoptotic activity.

Phase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas

Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state.

New retinoid derivatives as back-ups of Adarotene.

Classical and novel retinoids: their targets in cancer therapy.

Genetic lesions in diffuse large B-cell lymphomas

The potential role of Aurora kinase inhibitors in haematological malignancies.

P304

378-386

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.13595

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

171

http://www.w3.org/2001/XMLSchema#string

P50

Francesco Bertoni

Emanuele Zucca

Luciano Cascione

P577

2015-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280632820

http://www.w3.org/2001/XMLSchema#string

P698

26235926

http://www.w3.org/2001/XMLSchema#string

The novel atypical retinoid ST5589 down-regulates Aurora Kinase A and has anti-tumour activity in lymphoma pre-clinical models.

about

P2860

P2860

The novel atypical retinoid ST5589 down-regulates Aurora Kinase A and has anti-tumour activity in lymphoma pre-clinical models.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698